Malaysian Genomics Resource Centre

Malaysian Genomics Resource Centre (MGRC) is a prominent genomics and biopharmaceutical company based in Malaysia, specializing in genome sequencing, bioinformatics, and genetic screening. Established in 2004, the company has evolved from a genomics service provider into a diversified life sciences entity with a strong focus on immunotherapy and regenerative medicine. MGRC operates high-throughput laboratories that provide genetic testing for clinical and consumer use, alongside a specialized cell processing facility for advanced therapies. Their current portfolio includes the development and commercialization of Natural Killer (NK) cell therapies and Chimeric Antigen Receptor T-cell (CAR-T) therapies for cancer treatment. Listed on the Bursa Malaysia, MGRC continues to expand its footprint across Southeast Asia through strategic partnerships in healthcare and biotechnology.